A study evaluating efficacy of Nab paclitaxel and Gemcitabine compared to FOLFIRINOX in patients with metastatic pancreatic cancer
Phase of Trial: Phase IV
Latest Information Update: 09 Apr 2018
Price : $35 *
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Carcinoma; Pancreatic cancer
- Focus Therapeutic Use
- 09 Apr 2018 New trial record
- 03 Apr 2018 Primary end point (Overall Survival) has been met as per the results published in the Investigational New Drugs.
- 03 Apr 2018 Primary end point (Progression Free Survival) has not been met as per the results published in the Investigational New Drugs.